Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.7.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Revenues:        
Grants $ 0 $ 0 $ 0 $ 148,054
Total revenues 0 0 0 148,054
Operating costs and expenses:        
Research and development 2,332,700 1,596,002 5,151,064 3,296,514
General and administrative 3,408,042 1,929,166 5,681,992 4,581,005
Total operating costs and expenses 5,740,742 3,525,168 10,833,056 7,877,519
Loss from operations (5,740,742) (3,525,168) (10,833,056) (7,729,465)
Interest and other expense (249,126) (262,807) (511,666) (463,280)
Net loss (5,989,868) (3,787,975) (11,344,722) (8,192,745)
Deemed dividend on inducement shares (5,220,000) 0 (5,220,000) 0
Deemed dividend on warrant reprice (19,413) 0 (19,413) 0
Net loss allocable to common stockholders $ (11,229,281) $ (3,787,975) $ (16,584,135) $ (8,192,745)
Basic and diluted net loss per share $ (1.47) $ (0.92) $ (2.37) $ (2.03)
Shares used to calculate basic and diluted net loss per share 7,662,700 4,128,617 6,985,943 4,037,835